Author

Mélanie Buchi

Observed names: Buchi, Melanie, Buchi, Mélanie, M Buchi, M. Buchi, Melanie Buchi

Institutions: University of Basel, University Hospital of Basel

Observed institutions: Novartis (Switzerland), University of Basel, University Hospital of Basel, Novartis Institutes for BioMedical Research

ORCID: 0000-0001-9958-9748

Observed ORCID: 0000-0001-9958-9748

OpenAlex ID: A5091717205

Synchronous Evolution of an Odor Biosynthesis Pathway and Behavioral Response

2012 · Qian Li, Wayne J. Korzan, et al. · Current Biology · 197

PDF

A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer

2019 · Lucia D’Amico, Ulrike Menzel, et al. · Journal for ImmunoTherapy of Cancer · 136

PDF

Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy

2023 · Marcel P. Trefny, Nicole Kirchhammer, et al. · Nature Communications · 99

PDF

Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy

2019 · Abhishek S. Kashyap, Martina Schmittnaegel, et al. · Proceedings of the National Academy of Sciences · 92

PDF

NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity

2022 · Nicole Kirchhammer, Marcel P Trefny, et al. · Science Translational Medicine · 88

PDF

Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity

2019 · Abhishek S. Kashyap, Tamara Thelemann, et al. · Journal for ImmunoTherapy of Cancer · 60

PDF

The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models

2018 · Heinz Läubli, Philipp Müller, et al. · Cancer Immunology Immunotherapy · 54

Neuropeptide S receptor deficiency modulates spontaneous locomotor activity and the acoustic startle response

2010 · Markus Fendt, Mélanie Buchi, et al. · Behavioural Brain Research · 47

Plinabulin, a Distinct Microtubule-Targeting Chemotherapy, Promotes M1-Like Macrophage Polarization and Anti-tumor Immunity

2021 · Marina Natoli, Petra Herzig, et al. · Frontiers in Oncology · 46

PDF

Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity

2023 · Laura Fernandez-Rodriguez, Chiara Cianciaruso, et al. · Journal for ImmunoTherapy of Cancer · 28

PDF

Narcoleptic episodes in orexin-deficient mice are increased by both attractive and aversive odors

2011 · Marta Morawska, Mélanie Buchi, et al. · Behavioural Brain Research · 20

Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors

2025 · Andreas Zingg, Reto Ritschard, et al. · Cancer Immunology Research · 11

Targeted apoptotic immune modulator for the treatment of metastatic EGFR-positive solid tumors

2025 · Derrick Broka, Shoshana Klein, et al. · Proceedings of the National Academy of Sciences · 4

Anti-PD1-IL18 immunoconjugate promotes effector T cell-mediated antitumor immunity

2026 · Nicole Oelgarth, Kea Martin, et al. · Journal for ImmunoTherapy of Cancer · 2

PDF

Data from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors

2025 · Andreas Zingg, Reto Ritschard, et al. · 1

SECN-15: A novel treatment option for patients with checkpoint inhibitor–resistant tumors by targeting Neuropilin-1 with antisense oligonucleotides.

2025 · André Maaske, Anne Sadewasser, et al. · Journal of Clinical Oncology · 1

PDF

Inhibition of Cbl-b restores effector functions of human intratumoral NK cells

2024 · Sofia Tundo, Marcel Trefny, et al. · Journal for ImmunoTherapy of Cancer · 1

PDF

Targeting poorly differentiated thyroid cancer with bispecific antibodies and CAR T cells from the human anti-TSHR autoantibody repertoire

2026 · Claudia Fischer, Anne Eugster, et al. · bioRxiv (Cold Spring Harbor Laboratory)

PDF

Figure S5 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors